Merck agrees to let other drug makers make its Covid pill
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Friday
August 12, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
FRIDAY, AUGUST 12, 2022
Merck agrees to let other drug makers make its Covid pill

Covid-19 in Bangladesh

UNB/AP
28 October, 2021, 08:40 am
Last modified: 28 October, 2021, 10:34 am

Related News

  • Merck's Covid-19 pill active against Omicron in lab studies
  • EU drug regulator OKs Pfizer Covid pill for high-risk patients
  • India allows emergency use of Merck's Covid-19 pill, two more vaccines
  • India committee recommends EUA for Merck's Covid-19 pill, two other vaccines - report
  • Vaccines, pills and data offer some Christmas cheer in face of Omicron advance

Merck agrees to let other drug makers make its Covid pill

UNB/AP
28 October, 2021, 08:40 am
Last modified: 28 October, 2021, 10:34 am
In this undated file image provided by Merck & Co. shows their new antiviral medication. The pharmaceutical Merck has agreed to allow other drugmakers worldwide to make its Covid-19 treatment, the first pill that has been shown to be effective against the disease, in a move aimed at helping millions of people in poorer countries access to the drug. In a statement on Wednesday, Oct. 27, 2021, the UN-backed Medicines Patent Pool said it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics. (Merck & Co. via AP, File)
In this undated file image provided by Merck & Co. shows their new antiviral medication. The pharmaceutical Merck has agreed to allow other drugmakers worldwide to make its Covid-19 treatment, the first pill that has been shown to be effective against the disease, in a move aimed at helping millions of people in poorer countries access to the drug. In a statement on Wednesday, Oct. 27, 2021, the UN-backed Medicines Patent Pool said it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics. (Merck & Co. via AP, File)

Pharmaceutical company Merck agreed to allow other drug makers to produce its Covid-19 pill, in a move aimed at helping millions of people in poorer countries get access to the potentially life-saving drug, a United Nations-backed public health organization said on Wednesday.

The Medicines Patent Pool said in a statement that it had signed a voluntary licensing agreement for molnupiravir with Merck and its partner Ridgeback Biotherapeutics.

The agreement will allow the Medicines Patent Pool to grant further licenses to qualified companies who are approved to make the drug. Neither drug maker will receive royalties under the agreement for as long as the World Health Organization deems Covid-19 to be a global emergency. Molnupiravir is the first pill that has been shown to treat the disease.

Charles Gore, the executive director of the Medicines Patent Pool, said the early results for molnupiravir were "compelling" and that he hoped this first voluntary licensing agreement for a Covid-19treatment would lead to others.

Despite repeated requests from governments and health officials, no vaccine makers have agreed to a similar deal. A hub set up by WHO in South Africa intended to share messenger RNA vaccine recipes and technologies has not enticed a single pharmaceutical to join.

Merck has requested its pill be licensed by both the US Food and Drug Administration and the European Medicines Agency, decisions that could come within weeks.

Merck reported this month that molnupiravir cut hospitalizations and deaths by half among patients with early symptoms of Covid-19. The results were so strong that independent medical experts monitoring the trial recommended stopping it early.

An antiviral pill that people could take at home to reduce their symptoms and speed recovery could prove groundbreaking, easing the crushing caseload on hospitals and helping to curb outbreaks in poorer countries with weak health care systems.

It would also bolster a two-pronged approach to the pandemic: treatment by way of medication and prevention, primarily through vaccinations.

The charity Doctors Without Borders welcomed the agreement Merck struck to share its Covid-19 pill, but said it didn't go far enough.

"The license excludes key upper-middle-income countries like Brazil and China from its territory, where there are strong, established capacity to produce and supply antiviral medicines," said Yuanqiong Hu, a senior legal and policy adviser at Doctors Without Borders, who called the deal "disappointing."

Top News

Merck / Merck & Co / Merck Covid-19 Pill / Merck pill

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Default loans jump Tk22,000cr in six months
    Default loans jump Tk22,000cr in six months
  • File Photo: Mohammad Minhaj Uddin/TBS
    ICDs hike imports handling charge by 35%
  • A shopping cart is seen in a supermarket as inflation affected consumer prices in Manhattan, New York City, US on 10 June 2022. REUTERS/Andrew Kelly
    Is global inflation nearing a peak?

MOST VIEWED

  • Photo: Courtesy
    US supports Bangladesh’s pediatric Covid-19 vaccination campaign
  • Photo: Collected
    Bangladesh logs 1 death, 214 Covid cases in 24 hours
  • Photo: Rajib Dhar/TBS
    Children 5-11 in age get first Covid vaccine shot
  • Representational image. Picture: Collected
    16 children to get trial Covid jabs on Thursday
  • Photo: Collected
    1 Covid death, 198 cases reported in a day
  • Illustration: Collected
    1 Covid death, 239 cases reported in 24hrs

Related News

  • Merck's Covid-19 pill active against Omicron in lab studies
  • EU drug regulator OKs Pfizer Covid pill for high-risk patients
  • India allows emergency use of Merck's Covid-19 pill, two more vaccines
  • India committee recommends EUA for Merck's Covid-19 pill, two other vaccines - report
  • Vaccines, pills and data offer some Christmas cheer in face of Omicron advance

Features

Bye bye! Photographer: Michael Zarrilli/Getty Images North America via Bloomberg

Three major takeaways from the FBI search on Trump’s home

19h | Panorama
Photo: Noor A Alam/TBS

Big dreams in small rooms: The aspiring nurses of Geneva Camp

21h | Panorama
Illustration: TBS

How to deal with toxic people at work

22h | Pursuit
Women were more likely to report leaving the workforce between March 2020 and September 2021 than their male counterparts. PHOTO: BLOOMBERG

Being single and smart is bad for your career if you are a woman

22h | Pursuit

More Videos from TBS

Control on liquor import boosts local Carew sales

Control on liquor import boosts local Carew sales

11h | Videos
Is Bangladesh losing opportunity to sent more expats to the Middle East?

Is Bangladesh losing opportunity to sent more expats to the Middle East?

12h | Videos
When hassles at airport will come to an end?

When hassles at airport will come to an end?

14h | Videos
How to spot a Pyramid Scheme?

How to spot a Pyramid Scheme?

15h | Videos

Most Read

1
Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 
Banking

Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 

2
Diesel price hiked by Tk34 per litre, Octane by Tk46
Energy

Diesel price hiked by Tk34 per litre, Octane by Tk46

3
Photo: Collected
Transport

Will Tokyo’s traffic model solve Dhaka’s gridlocks?

4
Arrest warrant against Habib Group chairman, 4 others 
Crime

Arrest warrant against Habib Group chairman, 4 others 

5
File Photo: State Minister for Power, Energy and Mineral Resources Nasrul Hamid
Energy

All factories to remain closed once a week under rationing system

6
Anwar Group looks beyond slowdown – invests Tk5,000cr
Economy

Anwar Group looks beyond slowdown – invests Tk5,000cr

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net